325 related articles for article (PubMed ID: 1345458)
21. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus.
Nakano M; Ohuchi Y; Hasegawa H; Kuroda T; Ito S; Gejyo F
J Rheumatol; 2000 Jun; 27(6):1403-7. PubMed ID: 10852261
[TBL] [Abstract][Full Text] [Related]
22. Anticardiolipin antibodies and disease activity in systemic lupus erythematosus.
Santiago MB; Viana V; Bueno C; Yoshinari N; de Oliveira RM; Cossermelli W
Rev Hosp Clin Fac Med Sao Paulo; 1990; 45(4):167-70. PubMed ID: 2135827
[TBL] [Abstract][Full Text] [Related]
23. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
Rodriguez VE; Gonzalez-Pares EN; Rivera C
P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and laboratory diagnosis of heart disease in systemic lupus erythematosus].
Alves LJ; Hydalgo L; Rolim LF; Campagnone GZ; Aidar MT; Novaes GS; Kalil G
Arq Bras Cardiol; 1997 Feb; 68(2):79-83. PubMed ID: 9433831
[TBL] [Abstract][Full Text] [Related]
25. [Anticardiolipin antibodies in rheumatic autoimmune diseases. Correlation with clinical and laboratory findings].
Llanos C; Inostroza J; Riedemann P; Ponce L; Kaliski S; Graf D; Aguayo O
Rev Med Chil; 1992 Nov; 120(11):1235-40. PubMed ID: 1340942
[TBL] [Abstract][Full Text] [Related]
26. The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosus.
Shergy WJ; Kredich DW; Pisetsky DS
J Rheumatol; 1988 Sep; 15(9):1389-94. PubMed ID: 3264338
[TBL] [Abstract][Full Text] [Related]
27. [Capacity to predict a recurrence of lupus erythematosus using double-stranded anti-DNA antibodies and Farr technique].
Massardo L; Martínez ME; Pérez R; Ramírez V; Foradori A; González A; Radrigán F; Gutiérrez F; Jacobelli S
Rev Med Chil; 1999 Apr; 127(4):411-20. PubMed ID: 10451606
[TBL] [Abstract][Full Text] [Related]
28. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
Frostegård J; Svenungsson E; Wu R; Gunnarsson I; Lundberg IE; Klareskog L; Hörkkö S; Witztum JL
Arthritis Rheum; 2005 Jan; 52(1):192-200. PubMed ID: 15641060
[TBL] [Abstract][Full Text] [Related]
29. Anti-centromere antibodies in patients with systemic lupus erythematosus.
Respaldiza N; Wichmann I; Ocaña C; Garcia-Hernandez FJ; Castillo MJ; Magariño MI; Magariño R; Torres A; Sanchez-Roman J; Nuñez-Roldan A
Scand J Rheumatol; 2006; 35(4):290-4. PubMed ID: 16882593
[TBL] [Abstract][Full Text] [Related]
30. [Significance of anticardiolipin antibodies in connective tissue diseases].
Scagliusi P; Tortorelli E; L'Abbate MC; Pipitone V
Minerva Med; 1989 Oct; 80(10):1059-68. PubMed ID: 2682375
[TBL] [Abstract][Full Text] [Related]
31. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
33. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
34. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
Komatireddy GR; Wang GS; Sharp GC; Hoffman RW
J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
[TBL] [Abstract][Full Text] [Related]
35. Antinucleosome antibodies and systemic lupus erythematosus.
Düzgün N; Sahin M; Genç Y; Tutkak H
Ann N Y Acad Sci; 2007 Aug; 1109():421-8. PubMed ID: 17785331
[TBL] [Abstract][Full Text] [Related]
36. [Anticardiolipin antibodies in patients with systemic lupus erythematosus].
Petrović R; Petrović M; Novicić-Sasić D; Damjanov N
Srp Arh Celok Lek; 1994; 122 Suppl 1():98-100. PubMed ID: 18173204
[TBL] [Abstract][Full Text] [Related]
37. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
38. Single anticardiolipin measurement in the routine management of patients with systemic lupus erythematosus.
Axtens RS; Miller MH; Littlejohn GO; Topliss DJ; Morand EF
J Rheumatol; 1994 Jan; 21(1):91-3. PubMed ID: 8151597
[TBL] [Abstract][Full Text] [Related]
39. Prolactin, estradiol and anticardiolipin antibodies in premenopausal women with systemic lupus erythematosus: a pilot study.
Tiskievicz F; Mallmann ES; Brenol JC; Xavier RM; Spritzer PM
Rev Bras Reumatol; 2011; 51(5):460-4. PubMed ID: 21952998
[TBL] [Abstract][Full Text] [Related]
40. Respiratory involvement in systemic lupus erythematosus. A clinical and immunological study.
Holgate ST; Glass DN; Haslam P; Maini RN; Turner-Warwick M
Clin Exp Immunol; 1976 Jun; 24(3):385-95. PubMed ID: 1084819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
